Dabigatran etexilate
HealthData.Gov
Updated Mar 23, 2026
About this dataset
Dabigatran Etexilate Mesylate is a generic prescription oral capsule medication, available in strengths of 75mg, 110mg, and 150mg (equivalent to base). Manufactured by Alembic Pharmaceuticals, it acts as a direct thrombin inhibitor to help prevent blood clots. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dabigatran etexilate
Access the FDA dataset for Dabigatran etexilate โ ANDA 214358 submitted by Mylan Institutional LLC
Modified Mar 23, 2026